Robert Francis Doman
Nessuna posizione attualmente
Relazioni attive
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Sandra Leung | F | 63 | 32 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Lamberto Andreotti | M | 73 | 19 anni | |
Yuval Cohen | M | 49 |
Celsus Therapeutics Plc
Celsus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Celsus Therapeutics Plc is a drug development company, which focuses on developing novel, first-in-class, non-steroidal, synthetic anti-inflammatory drugs and multi-functional anti-inflammatory drugs. The company main clinical candidates are MRX-5, MRX-6, MRX-4, CFX-1 and OPX-1. Celsus Therapeutics was founded on October 7, 2004 and is headquartered in London, the United Kingdom. | 8 anni |
Allan Shaw | M | 59 |
Celsus Therapeutics Plc
Celsus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Celsus Therapeutics Plc is a drug development company, which focuses on developing novel, first-in-class, non-steroidal, synthetic anti-inflammatory drugs and multi-functional anti-inflammatory drugs. The company main clinical candidates are MRX-5, MRX-6, MRX-4, CFX-1 and OPX-1. Celsus Therapeutics was founded on October 7, 2004 and is headquartered in London, the United Kingdom. | - |
Lawrence Hamilton | M | 66 | 8 anni | |
Priya Jambhekar | F | - | 3 anni | |
Amos Eiran | M | 87 |
Celsus Therapeutics Plc
Celsus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Celsus Therapeutics Plc is a drug development company, which focuses on developing novel, first-in-class, non-steroidal, synthetic anti-inflammatory drugs and multi-functional anti-inflammatory drugs. The company main clinical candidates are MRX-5, MRX-6, MRX-4, CFX-1 and OPX-1. Celsus Therapeutics was founded on October 7, 2004 and is headquartered in London, the United Kingdom. | 3 anni |
Leif Valdemar Johansson | M | 73 | 13 anni | |
Lewis B. Campbell | M | 77 | 18 anni | |
Gerald Bruce | M | 68 | 8 anni | |
Fouad Namouni | M | 55 | 21 anni | |
Laurie Glimcher | M | 72 | 20 anni | |
Charles Sigal | M | 72 | 16 anni | |
Anthony Hooper | M | 69 | 15 anni | |
Steven B. Ratoff | M | 81 | 16 anni | |
Robert Roche | M | 57 | 6 anni | |
Mark Trudeau | M | 62 | 11 anni | |
Julie Smith | F | 53 | - | |
Beth Anne Piper | M | - | 4 anni | |
Samuel Barker | M | 81 | - | |
Robert Peach | M | 68 | 9 anni | |
Lie Ping Chen | M | - | - | |
Mitchell P. Cybulski | M | 77 | 6 anni | |
John Baule | M | 59 | 9 anni | |
Larry K. Benedict | M | 63 | 7 anni | |
Kenneth E. Lebioda | M | - | 5 anni | |
Sharon Real | M | 60 | 3 anni | |
Shu Hui Chen | M | 61 | 5 anni | |
Joachim von Roy | M | 79 | - | |
Peter S. Linsley | M | 72 | 14 anni | |
James New | M | 70 | 12 anni | |
Benjamin Winograd | M | 63 | 9 anni | |
Laurie Alsup | M | 70 | 10 anni | |
Karen LaRochelle | F | 57 | 20 anni | |
Yadagiri R Pendri | M | 68 | 7 anni | |
Mike Werner | M | - | 4 anni | |
Elliott Levy | M | 65 | 17 anni | |
Ronald Marcus | M | 65 | 22 anni | |
Douglas Hay | M | - | 6 anni | |
Pablo Jimenez | M | 59 |
Celsus Therapeutics Plc
Celsus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Celsus Therapeutics Plc is a drug development company, which focuses on developing novel, first-in-class, non-steroidal, synthetic anti-inflammatory drugs and multi-functional anti-inflammatory drugs. The company main clinical candidates are MRX-5, MRX-6, MRX-4, CFX-1 and OPX-1. Celsus Therapeutics was founded on October 7, 2004 and is headquartered in London, the United Kingdom. | 2 anni |
Susan Holmes | F | - | 3 anni | |
Ning Yan | M | - | 7 anni | |
Steve Carchedi | M | 62 | 9 anni | |
Robert W. Morrissey | M | 66 | 6 anni | |
Wenqing Yao | M | 61 | 6 anni | |
Julia Henderson | F | 52 | 3 anni | |
Douglas C. Plessinger | M | 55 | 6 anni | |
Georgia Keresty | M | 62 | 4 anni | |
Paul von Autenried | M | 62 | 26 anni | |
Kevin McManus | M | - | 9 anni | |
Cheryl Capps | F | 62 | 13 anni | |
Lucius Allen | M | - | - | |
Miguel Forte | M | 63 | 5 anni | |
Richard Colonno | M | 74 | 16 anni | |
Philippe Deschamps | M | 62 | 12 anni | |
Gary Dickinson | M | 72 | 4 anni | |
Robert Rebak | M | 57 | 2 anni | |
William Jones | M | 60 | 12 anni | |
Stuart Tross | M | 57 | 8 anni | |
Helen Torley | M | 61 | 5 anni | |
Phillip John Brancazio | M | 71 | 23 anni | |
Susan Mahony | M | 59 | 5 anni | |
Anthony A. McBride | M | 60 | - | |
Kevin Rooney | M | 58 | 6 anni | |
Michael A. Popson | M | - | 6 anni | |
Timothy McNamara | M | 67 | 9 anni | |
William F. O'Dell | M | 77 | 7 anni | |
Vance D. Coffman | M | 79 | 9 anni | |
Barry A. Labinger | M | 60 | 3 anni | |
James G. Ham | M | 74 | 7 anni | |
John L. McGoldrick | M | 83 | 10 anni | |
Steven E. Benner | M | 64 | 7 anni | |
Timothy P. Cost | M | 65 | 5 anni | |
Gregory A. Fischer | M | - | 12 anni | |
Richard J. White | M | 82 | 12 anni | |
Stephen K. Carter | M | 85 | 13 anni | |
Ellen Futter | F | 74 | 6 anni | |
Christine Poon | F | 71 | 3 anni | |
Kenneth F. Anderson | M | - | 17 anni | |
Mark E. McGovern | M | 70 | 11 anni | |
David E. Martin | M | 57 | 2 anni | |
Zola P. Horovitz | M | 89 | - | |
Marino Carol | F | - | 8 anni | |
Rick Winningham | M | 64 | 4 anni | |
Hank Safferstein | M | - | 3 anni | |
Michael Loberg | M | 76 | 18 anni | |
Jaisim Shah | M | 63 | 3 anni | |
N. Coles | M | 63 | - | |
Walter R. Maupay | M | 84 | - | |
Luigi Lenaz | M | 83 | 19 anni | |
Daniel Lynch | M | 65 | 15 anni | |
Robert A. Ashley | M | 66 | 5 anni | |
Nicole Onetto | M | 71 | 6 anni | |
Frederick B. Oleson | M | - | 9 anni | |
Barry Wilson | M | 80 | 13 anni | |
William R. Miller | M | 95 | 27 anni | |
Kenneth E. Weg | M | 85 | 10 anni | |
Stephen Sadove | M | 72 | 10 anni | |
Julius A. Vida | M | 95 | 18 anni | |
David Wishart | M | - | 10 anni |
Statistiche
Paese | Relazioni | % del totale |
---|---|---|
Stati Uniti | 94 | 94.00% |
Regno Unito | 4 | 4.00% |
Svizzera | 2 | 2.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Robert Francis Doman
- Contatti personali